Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study-Reference-Cited by-同舟云学术

Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study

Published:2020-05 Issue: Volume:146 Page:21-28
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Greco Carlo,Pares Oriol,Pimentel Nuno,Louro Vasco,Morales Javier,Nunes Beatriz,Vasconcelos Ana Luisa,Antunes Ines,Kociolek Justyna,Stroom Joep,Viera Sandra,Mateus Dalila,Cardoso Maria Joao,Soares Ana,Marques Joao,Freitas Elda,Coelho Graca,Fuks Zvi

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. The evolving role of external beam radiotherapy in localized prostate cancer;Greco;Semin Oncol,2019

2. Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics;Proust-Lima;Int J Radiat Oncol Biol Phys,2011

3. Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis?;Fowler;Anticancer Res,2013

4. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial;Widmark;Lancet,2019

5. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years;Katz;Radiat Oncol,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

3. Treatment Accuracy Dependent Dose Constraints and Oar Safety Margins;2024

4. Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review;Practical Radiation Oncology;2023-10

5. Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial);BMC Cancer;2023-03-23